2021-01-04

Nine Treasures Hall Group President's 2021 New Year Message

As the sun and moon usher in a new beginning, and light and brilliance pave the way for a fresh chapter, we bid farewell to 2020—a year marked by challenges yet brimming with determination and achievement—and warmly welcome 2021, a year filled with boundless hope and inspiring momentum. On this momentous occasion, as we celebrate the turning of the calendar and embrace the promise of a new year, I, on behalf of the Jiuzhitang Group, extend my sincerest wishes and heartfelt gratitude to every employee who has dedicated their hard work to the company’s growth over the past year, as well as to all our valued friends from society who have shown unwavering support and encouragement for Jiuzhitang’s continued development!

+

2020-12-23

Jiuzhitang Maker Approved to Establish a Sub-station of the Postdoctoral Research Workstation

Jiuzhitang Maker has been approved to establish a sub-station of its postdoctoral research workstation, which will further elevate Jiuzhitang Maker’s efforts in cultivating top-tier industry talent, enhancing research quality, and accelerating the integration of industry, academia, research, and application.

+

2020-12-22

Good News: Jiuzhitang Honored with Multiple Rankings at the 2nd China Traditional Chinese Medicine Brand Building Conference!

Jiuzhitang, leveraging its strong brand leadership, proudly secured a spot on both the "2020 Time-Honored Chinese Medicine Brand List" and the "Top 10 Traditional Chinese Medicine Enterprises" rankings. Meanwhile, Jiuzhitang's two flagship products—Shuxuetong Injection and Liuwei Dihuang Wan—each generating over 100 million yuan in sales, were recognized on the "Clinical-Value-Oriented Traditional Chinese Medicine Brand List"!

+

2020-12-08

Jiuzhitang Maker invited to attend the 2nd China Anti-Aging Conference

During the keynote forum's interactive interview session, Dr. Gao Yansong, Vice President of Jiuzhi堂 Group and General Manager of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereinafter referred to as Jiuzhitang Maker), delivered a keynote speech titled "Exploring Stem Cell Therapy for COVID-19," sharing with the audience how the century-old Jiuzhi堂 has been actively contributing to the fight against the pandemic.

+

2020-11-05

Join the stroke patient support group and stay updated on stem cell clinical trials!

In February 2020, Jiuzhitang Maker’s clinical trial for a new stem-cell drug received approval—marking the first clinical trial to utilize imported stem cells, the first to target a major neurological indication with stem-cell therapy, and also the first trial approved under the National Medical Products Administration’s resumption of accepting applications for stem-cell clinical trials, specifically one employing bone marrow-derived mesenchymal stem cells. To foster a friendly platform for meaningful exchange, we’ve established a dedicated online community for stroke patients, providing a space where participants can stay updated on stem-cell clinical trial developments, share their medical experiences, and learn from each other’s insights.

+

2020-10-26

Big news! Setting a new industry standard for quality — Jiuzhitang awarded the "National Quality Benchmark" title.

In the national quality benchmark selection event organized by China's Ministry of Industry and Information Technology and the China Association for Quality, Jiuzhitang was awarded the title of "2020 National Quality Benchmark."

+

2020-08-10

Jiuzhitang Maker丨We’re Hiring! Join us—your dream job awaits!

Jiuzhitang Maker is proudly seeking talented individuals! Positions such as Marketing Director, Cell Culture Technician, and CSV Validation Engineer are currently open—join us and let’s create brilliance together!

+

2020-07-24

Jiuzhitang Maker丨Recruiting Team Members—We’re Looking for You, the One Who Stands Out

Jiuzhitang Maker is proudly seeking talented individuals—join us if you’re ready to stand out! We’re hiring for roles such as Academic Support and Product Manager. Let’s collaborate to build a brighter future together!

+

2020-07-20

Jiuzhitang Maker CEO Gao Yansong: Embracing the Age of Stem-Cell Pharmaceuticals

Recently, a reporter from MedMakers' "PeakTalk Interview" conducted an exclusive interview with Dr. Gao Yansong, Vice President of Jiuzhitang Group and Deputy General Manager of Jiuzhitang Co., Ltd., as well as CEO of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. Here's the original text:

+
< 1...567...10 >